A world in which the responsible application of science and technology leads to better health for people and populations. We want science to work for health. We support the responsible development and ...

Cell-free fetal nucleic acids for non-invasive prenatal diagnosis is the result of a project funded and led by the PHG Foundation. An expert Working Group including GPs, obstetricians, midwives, ...

Discover how research is uncovering links between climate change, environmental exposures, and genomics to inform future healthcare and public health strategies.

Transcriptomics is the analysis of the transcriptome, the collection of all ribonucleic acid (RNA) that is present in a sample (a cell, tissue or organ) at a given time. RNA performs many functions ...

The European Union introduced the General Data Protection Regulation (GDPR) in 2018 and it forms part of current UK law. A long and complex piece of legislation, the GDPR governs the processing of ...

Visual identifiers in the care of people with dementia, addresses the ethical and legal issues affecting the use of visual identifiers in hospitals, exploring issues such as patient autonomy, consent, ...

Advances in clinical genomics have been enabled by short-read sequencing (SRS) technologies, where the DNA is broken into pieces up to 300 base pairs long. While these technologies have many ...

Citizen generated data (CGD) is a collective term for the data generated by people outside health systems. It can provide insights into health and wellbeing which could contribute to prediction and ...

Any changes in healthcare practice, including the introduction of tests, often requires consideration of their value. Clinical utility is a broad term that is used to denote this usefulness or value ...

On Friday the High Court ruled on the case of ABC v St George’s NHS Trust (and other NHS defendants). This is a significant decision with implications for a wide range of healthcare professionals ...

This strategy forms the basis for our approach between 2025 and 2030. Throughout this period, we will work with researchers, health professionals and policy makers, and across the commercial, ...

The impetus for convening this meeting came from recent progress in genomic and related research, particularly as a result of the accelerating generation and accumulation of data, the elaboration of ...